Skip to main content

Market Overview

32 Stocks Moving In Tuesday's Mid-Day Session



  • SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
  • EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication,, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
  • Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
  • Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
  • Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
  • Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
  • Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
  • Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
  • Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
  • Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
  • Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
  • Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
  • Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
  • New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 8.1 percent to $93.86 after reporting Q3 results.
  • Weatherford International plc (NYSE: WFT) gained 7.3 percent to $2.78 after the company reported a narrower-than-expected quarterly loss.
  • Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 5.4 percent to $6.90 after declining 1.50 percent on Monday.
  • SAP SE (NYSE: SAP) rose 4.3 percent to $110.52 after the company posted strong quarterly results and raised its outlook for the year.
  • Caterpillar Inc. (NYSE: CAT) rose 3.6 percent to $159.4604 following better-than-expected quarterly results.

Check out these big penny stock gainers and losers


  • Valeritas Holdings Inc (NASDAQ: VLRX) tumbled 29 percent to $1.81. Valeritas priced its 13.7 million share offering at $1.75 per share.
  • Stepan Company (NYSE: SCL) dropped 14.5 percent to $76.29 as the company posted downbeat Q1 results.
  • Casa Systems, Inc. (NASDAQ: CASA) fell 14 percent to $25.64 after announcing a 7.35 million share common stock offering.
  • Epizyme, Inc. (NASDAQ: EPZM) declined 12.6 percent to $13.37. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) shares fell 12.1 percent to $17.45.
  • BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares dropped 11.5 percent to $8.00.
  • Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares declined 10.5 percent to $3.23.
  • Waters Corporation (NYSE: WAT) dipped 8.6 percent to $191.51 following Q1 results.
  • Inspired Entertainment, Inc. (NASDAQ: INSE) dropped 8.6 percent to $4.80.
  • VirnetX Holding Corp (NYSE: VHC) shares declined 7.6 percent to $2.73.
  • Erin Energy Corporation (NYSE: ERN) shares slipped 7.6 percent to $2.495.
  • 3M Company (NYSE: MMM) dropped 7.4 percent to $200.03 after reporting Q1 results.
  • Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.9 percent to $15.24 after rising 9.80 percent on Monday.
  • Incyte Corporation (NASDAQ: INCY) fell 6.1 percent to $64.00. Lilly and Incyte disclosed that the FDA Advisory Committee recommended approval of baricitinib 2mg, but not 4mg, for the treatment of moderately-to-severely active RAI.

Related Articles (AMZN + ATOS)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at